Viewing Study NCT02035956

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-20 @ 6:38 PM
Study NCT ID: NCT02035956
Status: COMPLETED
Last Update Posted: 2020-01-18
First Post: 2014-01-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: IVAC MUTANOME Phase I Clinical Trial
Sponsor: BioNTech RNA Pharmaceuticals GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IVAC MUTANOME View
None IVAC View
None personalized therapy View
None personalized immuno therapy View
None RB_0004-01 View
None Ribological View
None Melanoma View
None cancer vaccine View